BLS & Co. and its energy services affiliate, Sugarloaf Associates, identified nine "Data Center Qualified Sites" for American Electric Power (NYSE: AEP), one of the nation's largest utilities.  After a comprehensive review of locations across AEP's 11-state territory, BLS & Co. qualified sites with reliable and redundant power supply, strong fiber networks, low disaster risks and a business-friendly climate. 

The team designed a three-phase evaluation process that analyzed the electric supply and capacity, access to long and short-haul fiber providers, water availability, electric costs, tax exemptions and incentives, demographics, vendor/supplier networks and the ability to complete construction within 18 months.  

As an extra step, a third-party engineering company modeled each site's ability to accommodate a 100,000-square-foot raised-floor data center designed to current industry standards.

BLS/Sugarloaf also completed an analysis of sites in 2 states for AEP data center / operations facility.  The team review the infrastructure, both manmade and natural disaster risks and the proximity of service providers to support a data center.

TradePoint Atlantic (TPA) – previously Sparrows Point Terminal – is a former 3,200 acre Bethlehem Steel plant site located in southeastern Baltimore County, Maryland.  TPA purchased the brownfield site in the fall of 2014 with plans to redevelop it into a major East Coast multi-modal distribution and manufacturing hub.

BLS & Co. was engaged to develop a comprehensive strategy to secure the public financing sources needed to mitigate the significant cost of repositioning a brownfields site of this scale and complexity.  Our services included:

• Benchmark analysis of the location’s incentives competitiveness versus similar competitive locations in seven other states;
• Management of a multi-firm team responsible for identifying and prioritizing available federal, state and local grant, incentives and financing programs to allow the developer to pursue environmental remediation and infrastructure improvements beyond what would otherwise be possible given market-based ROI targets;
• Development and execution of an overall strategy to design new incentives tools to improve the competitiveness of the site for potential tenants; and
• Development of a strategy for pursuit of public site development/remediation financing.

The competitive benchmarking analysis revealed an opportunity to improve the cost competitiveness of the site via the introduction of a targeted sales and use tax exemption for specified construction materials and warehousing equipment.  BLS & Co. served as “subject matter expert” to assist TPA in pursuit of the required legislation by documenting the competitive market-based rationale for the proposed exemption, providing data on similar programs in other locations, drafting proposed legislation and providing expert testimony during Senate and House hearings on the proposed legislation.  On May 19, 2016, Maryland Governor Larry Hogan signed the enabling legislation.

BLS & Co. served as financial advisor for a groundbreaking cooperative venture between the H. Lee Moffitt Cancer Center in Tampa and Merck to secure public financing to create over 300,000 square feet of life-sciences oriented development on a 25-acre site.

Moffitt created a wholly owned subsidiary called M2Gen to implement the project, which began with the construction of a 50,000 square foot facility that will house labs and related facilities focused on revolutionizing the way cancer is diagnosed and treated.

BLS & Co. conceptualized the incentives package for the project and managed the analysis, negotiations, structuring, approvals and documentation of the public financing. The public financing package constituted more than one-fourth the total project capitalization.

BLS & Co. represented Fanatics, the leading sports merchandise licensing and ecommerce company, in siting its second fulfillment and light manufacturing center in Frazeysburg, Ohio. The company was experiencing rapid growth, but had continued to process all of its orders from a single fulfillment center located in Florida. In order to maximize efficiency and lower costs while maintaining Fanatic's commitment to fast and reliable delivery, the Company sought to expand its fulfilment network.

During an approximately 6-month engagement, BLS & Co. conducted a comprehensive, multi-state site selection effort focusing on such factors as available real estate, ability to attract and retain labor, comprehensive cost modeling, and incentives. BLS & Co. then helped the company secure an Ohio Jobs Creation Tax Credit and a forgivable equipment lease financing.

BLS & Co. advised New York Life on the relocation of approximately 1,000 employees from the company’s Manhattan headquarters location to a new facility in Westchester, New York.

BLS & Co. was successful in securing an economic development incentive package that included a PILOT (Payment in Lieu of Taxes), sales tax exemptions on construction materials and FF&E purchases, a state capital grant and a discount of the utility bills.

When Roche required assistance to fast-track a decision on the location of its new Translational Clinical Research Center (TCRC), the company engaged BLS & Co. to secure incentives in support of this elite research early development organization. After a thorough site selection process, the company chose the build-to-suit Alexandria Center on Manhattan’s east side for its new facility.

BLS & Co. served as site selection and incentives consultant for Bristol-Myers Squibb's new North American Capability Center (NACC) in Tampa, FL. BMS’ goal for the NACC was to house key enterprise services—technology, finance, and accounting—together with research and analytics, and to do so in a cost-effective market. The NACC project required BLS & Co. to identify and prove out low-cost, yet high-quality, markets with diverse pools of talent.

BLS & Co. managed a team of brokers, designers, and the company’s own human resource, technology, and function heads during an engagement that resulted in the successful site selection, incentive agreement, staffing, and opening of the NACC—all within a nine-month window.

Our firm also served as site selection and incentives consultant during a complex and highly competitive nationwide search for the location of a new $750 million, large-scale multi-product bulk biologics facility in Devens, MA. The facility (the largest capital investment in BMS history) supports the production of ORENCIA (R), the company's biologic therapy for rheumatoid arthritis.

BLS & Co. serves as location and incentives advisor to biotechnology industry leader Genentech, the South San Francisco-based member of the Roche Group.  Genentech develops, manufactures and commercializes medicines to treat patients worldwide with serious medical conditions.  During our most recent engagement for Genentech, BLS & Co. managed a nationwide search for a second location for their Access Solutions Patient Service Center.  Access Solutions employees help patients understand their insurance benefits; find ways to help those who cannot afford their Genentech medicines; and work with doctors and pharmacists to deliver medicines to patients.  With the advice and guidance of the firm, Genentech selected Portland, OR for this mission critical operation, which opened for business in May 2019. The new Portland Patient Access Center employs approximately 175 full-time specialists and an almost equal number of contingent employees during the peak insurance benefit open season. The firm also advised Genentech on an Oregon Business Retention Program (BEP) grant and various market-entry strategies.